⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
QURE News
uniQure N.V.
Pomerantz LLP Advises of Securities Class Action Against uniQure N.V. – QURE
accessnewswire.com
QURE
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm
businesswire.com
QURE
INVESTOR ALERT: Securities Class Action Filed Against uniQURE N.V. – Investors Encouraged to Contact Kirby McInerney LLP
businesswire.com
QURE
Class Action Announcement for uniQure N.V. (QURE): Kessler Topaz Meltzer & Check, LLP Announces the Firm Has Filed a Securities Class Action Lawsuit Against uniQure N.V.
globenewswire.com
QURE
QURE DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026
businesswire.com
QURE
Rosen Law Firm Urges uniQure N.V. (NASDAQ: QURE) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
businesswire.com
QURE
Bronstein, Gewirtz & Grossman LLC Urges uniQure N.V. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
QURE
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of uniQure N.V. (QURE) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm
globenewswire.com
QURE
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
businesswire.com
QURE
Pomerantz LLP Advises Investors of Class Action Against uniQure N.V. – QURE
accessnewswire.com
QURE